The health technology assessment unit within the French Supreme Health Authority, Haute Autorité de Santé (HAS), is carrying out an assessment of extracorporeal photopheresis (ECP), a leukapheresis-based immunomodulatory therapy for the treatment of cutaneous T-cell lymphoma (CTCL). One ...
Please Login to read the full article.
